Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
144M
-
Number of holders
-
213
-
Total 13F shares, excl. options
-
126M
-
Shares change
-
-1.92M
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
-$35.4M
-
Put/Call ratio
-
1.62
-
Number of buys
-
109
-
Number of sells
-
-118
-
Price
-
$12.43
Significant Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock (MRVI) as of Q2 2023
265 filings reported holding MRVI - MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock as of Q2 2023.
MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock (MRVI) has 213 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126M shares
of 144M outstanding shares and own 87.51% of the company stock.
Largest 10 shareholders include GTCR LLC (21.7M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (11.2M shares), VANGUARD GROUP INC (10.6M shares), Thrivent Financial for Lutherans (8.31M shares), BlackRock Inc. (5.75M shares), MACKENZIE FINANCIAL CORP (3.55M shares), 12 West Capital Management LP (3.36M shares), Clearbridge Investments, LLC (3.11M shares), TWO SIGMA ADVISERS, LP (2.48M shares), and Alyeska Investment Group, L.P. (2.48M shares).
This table shows the top 213 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.